Why 340B Rebates Are Off — For Now
January was set to be the first month of a new 340B rebate pilot program, marking a seismic shift in how the drug discount program functions. But a flurry of court activity just before and after the new year put a sudden pause on the rebate program and left the future of the rebate pilot in questio…
CMS Announces Part D Savings & 2026 Maximum Fair Prices for First 10 Medicare-Negotiated Drugs
The first round of Medicare Part D negotiated drug prices is here! Find out which prescriptions are included and the savings your clients can see beginning in CY 2026!
Read the text version
Contact the Agent Survival Guide Podcast! Email us ASGPodcast@Ritterim.com or call 1-717-562-7211 a…
How Medicare Price Caps Will Affect Your 340B Hospital
About three years after being signed into law, one provision of the Inflation Reduction Act (IRA) that is of particular importance to 340B hospitals is about to take effect: Medicare price caps. Jan. 1, 2026, marks the date that the first 10 Medicare drugs will be subject to a maximum fair price (M…
Hot Topics in CV Nursing Advocacy: Inflation Reduction Act
You may know of the Inflation Reduction Act (IRA), but are you familiar with the fact that it is one of the largest pieces of healthcare legislation in the past few decades?!
Join Ryan Gough, Executive Director of the Partnership to Advance Cardiovascular Health (PACH) as he walks us through the b…
The Inflation Reduction Act's Impact on 340B
The Inflation Reduction Act (IRA) was enacted last year, and it includes a significant drug pricing component that will affect 340B savings on some of the drugs that cost the most for Medicare. In this episode, we are joined by Meetali Desai, director of pharmacy business services at UMass Memorial…
Tracey Spangenberg, Associate Chief Pharmacy Officer at UC San Diego Health
In this episode, Tracey Spangenberg, Associate Chief Pharmacy Officer at UC San Diego Health, joins the podcast to discuss system growth and early successes across the organization. She shares insights on the expanding role of outpatient care and retail pharmacy, outlines key challenges facing phar…
Roya Tran, PharmD, MS, 340B ACE, Associate Chief Pharmacy Officer for Pharmacy Finance and Supply Chain at Duke Health
In this episode, Roya Tran, PharmD, MS, 340B ACE, Associate Chief Pharmacy Officer for Pharmacy Finance and Supply Chain at Duke Health, joins the podcast to discuss her experience with the 340B program and how it supports access to care. She shares perspectives on expanding the ambulatory pharmacy…
Business As Usual...Until It Isn't: MDPNP's Impact on 340B with Julie Crozier, CEO of Secure340B
Send us Fan Mail
Schedule an Rx AssessmentWith Medicare’s Maximum Fair Price (MFP) rebates officially underway and the 340B rebate mechanism on hold, pharmacy owners are left navigating one of the grayest areas the industry has seen in years.In this episode, Scotty Sykes, CPA, CFP®, Bonnie Bond, CP…
280: The questions Advisory Board is asking in 2026
Advisory Board is here to do two things: tackle the toughest questions keeping healthcare leaders up at night, and push leaders' thinking on the questions they aren’t asking – but should be. In 2025, we navigated a landscape of major shifts, from policy changes, the growing presence of AI, drug inn…
Maximum Fair Price, the IRA, and What DC Means for 2026 and Beyond | Framework Focus
In this episode of Framework Focus, Dr. Dae Lee breaks down the regulatory and reimbursement shifts reshaping long-term care (LTC) pharmacy. With the Inflation Reduction Act (IRA) moving from policy theory to operational reality, Medicare’s Maximum Fair Price (MFP) program, Part D redesign, and inf…
Podcast 搜尋引擎
您可以使用我們的網站按人物、地點或主題搜尋3,825,376Podcast 和195,868,160單集。
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
